Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Molecular Therapy. Methods & Clinical Development
|
September 21, 2020
CERE-120 Prevents Irradiation-Induced Hypofunction and Restores Immune Homeostasis in Porcine Salivary Glands
Isabelle M A Lombaert, Vaishali N Patel, Christina E Jones, et al.
The Lancet. Respiratory Medicine
|
March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
Matthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
Emerging Infectious Diseases
|
August 21, 2015
Twenty Years of Active Bacterial Core Surveillance
Gayle Langley, William Schaffner, Monica M Farley, et al.
SSM - Population Health
|
September 27, 2016
Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study
Ruth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
The Journal of Infectious Diseases
|
April 19, 2008
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005
Matthew R Moore, Robert E Gertz, Robyn L Woodbury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand
Henry C Baggett, Leonard F Peruski, Sonja J Olsen, et al.
BMJ Open
|
August 31, 2017
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA
Ruth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
The Lancet. Infectious Diseases
|
February 7, 2015
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Journal of Infectious Diseases
|
September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness
Nicholas D Walter, Gavin B Grant, Utpala Bandy, et al.
JCI Insight
|
February 8, 2022
Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS
Meredith A Mortberg, Hien T Zhao, Andrew G Reidenbach, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Molecular Therapy. Methods & Clinical Development
|
September 21, 2020
CERE-120 Prevents Irradiation-Induced Hypofunction and Restores Immune Homeostasis in Porcine Salivary Glands
Isabelle M A Lombaert, Vaishali N Patel, Christina E Jones, et al.
The Lancet. Respiratory Medicine
|
March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
Matthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
Emerging Infectious Diseases
|
August 21, 2015
Twenty Years of Active Bacterial Core Surveillance
Gayle Langley, William Schaffner, Monica M Farley, et al.
SSM - Population Health
|
September 27, 2016
Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study
Ruth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
The Journal of Infectious Diseases
|
April 19, 2008
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005
Matthew R Moore, Robert E Gertz, Robyn L Woodbury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand
Henry C Baggett, Leonard F Peruski, Sonja J Olsen, et al.
BMJ Open
|
August 31, 2017
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA
Ruth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
The Lancet. Infectious Diseases
|
February 7, 2015
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Journal of Infectious Diseases
|
September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness
Nicholas D Walter, Gavin B Grant, Utpala Bandy, et al.
JCI Insight
|
February 8, 2022
Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS
Meredith A Mortberg, Hien T Zhao, Andrew G Reidenbach, et al.
Page
of 11